AcroMetrix is a company that operates out of facilities in Benicia, California and Alkmaar, the Netherlands and offers a comprehensive range of molecular products designed to meet specific customer needs. The range of their products includes controls and standards that assist the implementation and monitoring of diagnostic assays for clinical laboratories, blood centers and manufacturers. They’re one of the leading manufacturers of molecular quality control standards and controls used for clinical diagnostic and blood testing laboratories.

AcroMetrix combines well-characterized, consistent quality control products and internet-based solutions to interpret and manage results. With AcroMetrix, laboratories will find it easy to validate new assays, train technicians and set standards when creating notable quality control programs.

AcroMetrix recently announced the release of the OptiQuant-S HCV RNA Quantification Panel. The new panel uses their proprietary SynTuraÔ Technology and gives labs the critical ingredient to fully optimize the Hepatitis C molecular assays available in today’s market.

It’s commonly known in the medical community that viral Hepatitis C and B currently account for more than 75% of all cases of liver disease around the world. 1 HCV patients are monitored routinely to observe changes in the amount of virus, otherwise known as viral load, when undergoing treatment for the disease. It’s important that doctors get accurate viral load data from testing provided by the laboratory so they can adjust and manage any drug therapy the patient requires.

The President and CEO of AcroMetrix recently was quoted as saying, “OptiQuant-S HCV represents our continued commitment to Hepatitis C diagnostic testing. Medical laboratories utilizing the new OptiQuant-S HCV Panel will experience the benefits of a standardized product that offers consistent results with an enhanced dynamic range; and as a result reducing patient re-testing requirements and increasing savings in both labor and reagent costs.”

What makes the SynTuraÔ Technology special is that it involves a second generation viral RNA material that acts similar to enveloped mammalian RNA viruses like HCV or HIV. The new technology facilitates synthetic sequences to be inserted into mammalian RNA virus that are shown to be stable in replication and able to form infectious RNase resistant virus particles. This proprietary system is useful in the designing of defined RNA positive controls, quantification standards, internal controls and calibrators.

If you’re interested in this new technology or the other molecular products designed by AcroMetrix, visit them at www.acrometrix.com

Additional Resources

AcroMetrix :: Home Page

AcroMetrix :: Article on 800review.com

AcroMetrix :: Listed on Betaflow.com

AcroMetrix :: Information on Incprofile.com

AcroMetrix :: Article on Review inc.com

AcroMetrix :: Facts on 4worklife.com